Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK.

Wei J. et al, (2023), Nat Commun, 14

Employment outcomes of people with Long Covid symptoms: community-based cohort study

Ayoubkhani D. et al, (2023)

Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification

Pouwels KB. et al, (2023)

Implementing antibiotic stewardship in high prescribing English general practices: a mixed-methods study

TONKIN-CRINE S. et al, (2023), British Journal of General Practice

An analysis of 45 large-scale wastewater sites in England to estimate SARS-CoV-2 community prevalence

Morvan M. et al, (2022), Nature Communications, 13

Estimation of the impact of hospital-onset SARS-CoV-2 infections on length of stay in English hospitals using causal inference

POUWELS K. and Ben C., (2022), BMC Infectious Diseases

Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study.

Ayoubkhani D. et al, (2022), Open Forum Infect Dis, 9

Mortality risks associated with empirical antibiotic activity in Escherichia coli bacteraemia: an analysis of electronic health records.

Yoon CH. et al, (2022), J Antimicrob Chemother, 77, 2536 - 2545

Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom.

Vihta KD. et al, (2022), Clin Infect Dis, 75, e329 - e337

Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom.

Vihta KD. et al, (2022), Clin Infect Dis

Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a 'target trial'.

Pufulete M. et al, (2022), Open Heart, 9

uantifying the Primary and Secondary Effects of Antimicrobial Resistance on Surgery Patients: Methods and Data Sources for Empirical Estimation in England

POUWELS K., (2022), Frontiers in Public Health

Risk of COVID-19 related deaths for SARS-CoV-2 Omicron (B.1.1.529) compared with Delta (B.1.617.2)

Ward IL. et al, (2022), BMJ: British Medical Journal

SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection.

Wei J. et al, (2022), Nat Commun, 13

Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study.

Ayoubkhani D. et al, (2022), BMJ, 377

Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines.

Wei J. et al, (2022), Nat Med, 28, 1072 - 1082

Changes in the trajectory of Long Covid symptoms following COVID-19 vaccination: community-based cohort study

Ayoubkhani D. et al, (2022), BMJ: British Medical Journal

Author response.

Borek A. et al, (2022), Br J Gen Pract, 72

Risk of COVID-19 related deaths for SARS-CoV-2 Omicron (B.1.1.529) compared with Delta (B.1.617.2)

Ward I. et al, (2022)

Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study

Ayoubkhani D. et al, (2022)

Load More

1
2
3
4
5
6
7

Include forthcoming?